8-K: Concentra Group Holdings Reports Strong Q1 2026 Results

Concentra Group Holdings Parent, Inc. announced robust first-quarter 2026 financial results, including a 13.7% revenue increase and raised full-year guidance.

Summary

• Concentra Group Holdings Parent, Inc. reported strong financial results for the first quarter ended March 31, 2026.
• Revenue increased by 13.7% to $569.6 million compared to $500.8 million in Q1 2025.
• Net income rose by 28.7% to $52.3 million, with Adjusted Net Income Attributable to the Company at $51.5 million.
• Earnings per share were $0.39, and Adjusted Earnings per Share were $0.40.
• Adjusted EBITDA increased by 17.6% to $120.7 million.
• Patient visits grew by 6.7% to 3,419,091.
• The company raised its full-year 2026 guidance for revenue, Adjusted EBITDA, and Free Cash Flow.
• A cash dividend of $0.0625 per share was declared, payable on June 9, 2026.

Sentiment

Score: 8

Explanation: StockSavvy.ai views this as a positive report, with strong financial performance, raised guidance, and a consistent dividend, indicating a healthy and growing business.

Positives

• Revenue growth of 13.7% year-over-year to $569.6 million.
• Net income increased by 28.7% to $52.3 million.
• Adjusted EBITDA grew by 17.6% to $120.7 million, with a margin expansion of 69 basis points.
• Patient visits increased by 6.7% to 54,271 per day.
• Revenue per visit increased by 3.1% to $151.47.
• Raised full-year 2026 guidance for Revenue, Adjusted EBITDA, and Free Cash Flow.
• Opened one new de novo occupational health center and acquired three.
• Maintained a quarterly cash dividend of $0.0625 per share.

Negatives

• Net cash provided by operating activities was $21.0 million, a decrease from $11.7 million in the prior year's quarter.
• Free Cash Flow was $9.9 million, compared to negative $4.0 million in the prior year, indicating a significant swing but still a relatively small positive number.
• Capital expenditures decreased by 29.5% to $11.1 million, which could indicate a slowdown in investment if not managed carefully.
• Net leverage ratio remains at 3.4x, although the company is targeting below 3.0x by year-end.

Risks

• The frequency of work-related injuries and illnesses.
• Adverse changes to relationships with employer customers, third-party payors, or provider networks.
• Changes to regulations, new interpretations, or violations of regulations.
• State fee schedule changes by workers' compensation boards or other payors.
• Inability to realize reimbursement increases sufficient to keep pace with cost inflation.
• Labor shortages, increased employee turnover or costs, and union activity could increase operating costs.
• Competition from other occupational health centers and healthcare providers.
• Impacts of security breaches, cyberattacks, or data loss.

Future Outlook

The company raised its full-year 2026 guidance, now expecting revenue between $2.275 billion and $2.375 billion, Adjusted EBITDA between $460 million and $480 million, a net leverage ratio below 3.0x, and Free Cash Flow between $215 million and $235 million.

Management Comments

• "Our strong start to 2026 is a testament to the trust our clients place in us to care for their most valuable asset: their people."
• "The meaningful growth in visit volumes we saw this quarter demonstrates that our clinical model and value proposition continue to lead in workers' compensation."
• "Our Q1 results demonstrate the inherent strength of our operating model, with broad-based growth across our business supporting our decision to raise our full-year guidance."
• "As an independent company, we are optimizing our operational platform and infrastructure to drive sustained excellence and capitalize on our unique position as a leading health partner for the American workforce."

Industry Context

StockSavvy.ai notes that Concentra's performance aligns with a broader trend in the occupational health sector, where demand for comprehensive workplace health solutions is increasing due to a focus on employee well-being and productivity. The company's scale and diversified service offering position it favorably against competitors.

Comparison to Industry Standards

• Concentra's revenue growth of 13.7% in Q1 2026 outpaces the general healthcare services industry average, which has seen more moderate growth in recent quarters.
• The Adjusted EBITDA margin of 21.2% is strong within the occupational health sub-sector, indicating efficient operations.
• The company's focus on workers' compensation and employer services is a key differentiator, as many competitors may focus on broader healthcare services.

Legal Proceedings

• The filing mentions that significant legal actions could subject the company to substantial uninsured liabilities and that litigation and other legal and regulatory proceedings could adversely affect its business and financial statements.

Stakeholder Impact

• Shareholders: Benefit from a declared cash dividend of $0.0625 per share and potential share price appreciation due to strong financial performance and raised guidance. The company also repurchased shares.
• Employees: Continued focus on improving the health of the workforce may lead to a more stable and supportive work environment. Growth in operations could lead to job creation.
• Clients (Employers): Benefit from Concentra's continued focus on providing occupational health services, aiming to improve employee health and productivity.
• Creditors: The company's improved financial performance and target of reducing leverage may provide comfort regarding its ability to service debt.

Next Steps

• Continue to focus on achieving key strategic objectives.
• Position Concentra to deliver long-term shareholder value.
• Continue disciplined execution of the de novo pipeline.
• Optimize operational platform and infrastructure.
• Continue to de-lever for the remainder of 2026, targeting a net leverage ratio below 3.0x.
• Continue returning value to shareholders through the quarterly dividend and share repurchases.

Key Dates

Recommendation

The company delivered strong Q1 results and raised guidance, which is positive. However, the net leverage ratio remains a point of focus, and the company is still in the process of transitioning to a fully independent entity. While the performance is encouraging, a 'hold' recommendation allows for further observation of sustained performance and leverage reduction before considering a stronger rating.

Keywords

Occupational Health Services, Concentra Group Holdings, Q1 2026 Earnings, Revenue Growth, Adjusted EBITDA, Patient Visits, Dividend, Healthcare Provider